These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 32332118)

  • 1. Urokinase-Type Plasminogen Activator Protects Cerebral Cortical Neurons from Soluble Aβ-Induced Synaptic Damage.
    Diaz A; Merino P; Guo JD; Yepes MA; McCann P; Katta T; Tong EM; Torre E; Rangaraju S; Yepes M
    J Neurosci; 2020 May; 40(21):4251-4263. PubMed ID: 32332118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-Type Plasminogen Activator Triggers Wingless/Int1-Independent Phosphorylation of the Low-Density Lipoprotein Receptor-Related Protein-6 in Cerebral Cortical Neurons.
    Diaz A; Martin-Jimenez C; Woo Y; Merino P; Torre E; Yepes M
    J Alzheimers Dis; 2022; 89(3):877-891. PubMed ID: 35964187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plasminogen activating system in the pathogenesis of Alzheimer's disease.
    Yepes M
    Neural Regen Res; 2021 Oct; 16(10):1973-1977. PubMed ID: 33642369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.
    Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M
    J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase-type plasminogen activator (uPA) regulates the expression and function of growth-associated protein 43 (GAP-43) in the synapse.
    Merino P; Diaz A; Torre ER; Yepes M
    J Biol Chem; 2020 Jan; 295(2):619-630. PubMed ID: 31819012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plasmin system is induced by and degrades amyloid-beta aggregates.
    Tucker HM; Kihiko M; Caldwell JN; Wright S; Kawarabayashi T; Price D; Walker D; Scheff S; McGillis JP; Rydel RE; Estus S
    J Neurosci; 2000 Jun; 20(11):3937-46. PubMed ID: 10818128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase-type plasminogen activator (uPA) protects the tripartite synapse in the ischemic brain via ezrin-mediated formation of peripheral astrocytic processes.
    Diaz A; Merino P; Manrique LG; Cheng L; Yepes M
    J Cereb Blood Flow Metab; 2019 Nov; 39(11):2157-2171. PubMed ID: 29890880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase-type plasminogen activator promotes N-cadherin-mediated synaptic recovery in the ischemic brain.
    Diaz A; Merino P; McCann P; Yepes MA; Quiceno LG; Torre E; Tomkins A; Zhang X; Hales CM; Tong FC; Yepes M
    J Cereb Blood Flow Metab; 2021 Sep; 41(9):2381-2394. PubMed ID: 33757316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brain.
    Merino P; Diaz A; Manrique LG; Cheng L; Yepes M
    J Biol Chem; 2018 Jun; 293(24):9234-9247. PubMed ID: 29720403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase-type plasminogen activator inhibits amyloid-beta neurotoxicity and fibrillogenesis via plasminogen.
    Tucker HM; Kihiko-Ehmann M; Estus S
    J Neurosci Res; 2002 Oct; 70(2):249-55. PubMed ID: 12271474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-β(1-40) inhibits amyloid-β(1-42) induced activation of cytoplasmic phospholipase A2 and synapse degeneration.
    Bate C; Williams A
    J Alzheimers Dis; 2010; 21(3):985-93. PubMed ID: 20634578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase-type plasminogen activator promotes dendritic spine recovery and improves neurological outcome following ischemic stroke.
    Wu F; Catano M; Echeverry R; Torre E; Haile WB; An J; Chen C; Cheng L; Nicholson A; Tong FC; Park J; Yepes M
    J Neurosci; 2014 Oct; 34(43):14219-32. PubMed ID: 25339736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Aβ Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons.
    Rolland M; Powell R; Jacquier-Sarlin M; Boisseau S; Reynaud-Dulaurier R; Martinez-Hernandez J; André L; Borel E; Buisson A; Lanté F
    J Neurosci; 2020 Jul; 40(27):5161-5176. PubMed ID: 32444385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase-type plasminogen activator is a modulator of synaptic plasticity in the central nervous system: implications for neurorepair in the ischemic brain.
    Yepes M
    Neural Regen Res; 2020 Apr; 15(4):620-624. PubMed ID: 31638083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-β Load and Improves Memory in an Animal Model of Alzheimer's Disease.
    Akhter H; Huang WT; van Groen T; Kuo HC; Miyata T; Liu RM
    J Alzheimers Dis; 2018; 64(2):447-457. PubMed ID: 29914038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid beta-protein stimulates the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells.
    Davis J; Wagner MR; Zhang W; Xu F; Van Nostrand WE
    J Biol Chem; 2003 May; 278(21):19054-61. PubMed ID: 12754271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Plasminogen Activation System Promotes Neurorepair in the Ischemic Brain.
    Yepes M
    Curr Drug Targets; 2019; 20(9):953-959. PubMed ID: 30539695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses.
    Willén K; Sroka A; Takahashi RH; Gouras GK
    J Alzheimers Dis; 2017; 60(2):511-524. PubMed ID: 28869466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.